|
Originally published In Press as doi:10.1074/jbc.M208660200 on October 4, 2002
J. Biol. Chem., Vol. 277, Issue 49, 46912-46922, December 6, 2002
Characterization of a Unique Glycosylated Anchor
Endopeptidase That Cleaves the LPXTG Sequence Motif of Cell
Surface Proteins of Gram-positive Bacteria*
Sung G.
Lee,
Vijaykumar
Pancholi, and
Vincent A.
Fischetti
From the Laboratory of Bacterial Pathogenesis Rockefeller
University, New York, New York 10021
Received for publication, August 23, 2002, and in revised form, October 2, 2002
 |
ABSTRACT |
The precursors of most surface proteins on
Gram-positive bacteria have a C-terminal hydrophobic domain and charged
tail, preceded by a conserved LPXTG motif that
signals the anchoring process. This motif is the substrate for an
enzyme, termed sortase, which has transpeptidation activity resulting
in the cleavage of the LPXTG sequence and ultimate
attachment of the protein to the peptidoglycan. While screening a group
A streptococcal membrane extract for cleavage activity of the
LPXTG motif, we identified an enzyme (which we term
"LPXTGase") that differs significantly from sortase but also cleaves this motif. The enzyme is heavily glycosylated, which is
required for its activity. Amino acid composition and sequence analysis
revealed that LPXTGase differs from other enzymes, in that the
molecule, which is about 14 kDa in size, has no aromatic amino acids,
is rich in alanine, and is 30% composed of uncommon amino acids,
suggesting a nonribosomal construction. A similar enzyme found in the
membrane extract of Staphylococcus aureus, indicates that
this unusual molecule may be common among Gram-positive bacteria.
Whereas peptide antibiotics have been reported from bacillus species
that also contain unusual amino acids and are synthesized
non-ribosomally on amino acid-activating polyenzyme templates, this
would be the first reported enzyme that may be similarly synthesized.
 |
INTRODUCTION |
A large group of cell surface proteins of Gram-positive bacteria
are covalently anchored through their C termini to the cell wall
peptidoglycan. Most of these proteins are essential for pathogenic bacteria to establish successful infection of host tissues, and hence
they are considered virulence factors. Functionally, these surface
proteins may be divided into three major groups: viz. 1)
those with adhesin or invasion function (1-27); 2) those with antiphagocytic activities (28-40); and 3) those that are enzymes that
degrade surface components of host cells, thereby facilitating spread,
and enzymes that hydrolyze large molecules in the surroundings into
utilizable nutrients (29, 41-48).
A striking feature of all of these functionally and structurally
diverse surface proteins is that they all possess a carboxyl-terminal LPXTG sequence (49), which is cleaved during surface
translocation at the septum (50), resulting in a covalent linkage to
cell wall peptidoglycan. In all cases, the genes for these proteins contain additional nucleotide sequences following that which encodes the LPXTG. These additional sequences encode a stretch of
hydrophobic amino acids and positively charged C-terminal amino acids.
Pancholi and Fischetti (51) observed that the hydrophobic and
positively charged amino acid sequences are missing in the cell
wall-linked M protein, indicating that the precursor of M protein was
cleaved at a site within or immediately C-terminal to the
LPXTG sequence. These findings strongly indicated that
surface proteins become anchored to the cell wall by a common mechanism
(49). Subsequently, it was shown that deletion of either the
LPXTG or hydrophobic amino acid sequence or charged terminal
amino acid from the precursor of protein A of S. aureus
results in failure of protein A anchoring to the cell wall (52),
indicating that these sequences were essential for the cell
wall-anchoring process of these proteins. Collectively, these sequences
are considered to be a cell wall sorting signal, which has now been
shown to be present in over 100 surface proteins of Gram-positive
bacteria (53, 54).
Through a series of elegant experiments, Schneewind et al.
(55) have shown that the peptide bond between threonine and glycine of
the LPXTG sequence of protein A becomes cleaved by an enzyme termed sortase, after which the carboxyl terminus of threonine becomes
covalently attached to the amino group of one of the glycines of the
pentaglycine cross-bridge of the S. aureus cell wall.
Recently, they have shown that S. aureus mutants defective
in the anchoring of surface proteins to the cell wall carry a mutation
in srt gene (50). Subsequently, they cloned the
srtA gene in Escherichia coli and purified
recombinant sortase. In vitro, the purified sortase cleaved
the LPXTG sequence after threonine (56) and also covalently
attached the surface protein with C-terminal LPXT to a
triglycine substrate (57). These results indicate that sortase
possesses two functions, a specific endopeptidase and a transpeptidase.
In addition, they showed that S. aureus mutants lacking
sortase are unable to display surface proteins and are defective in
establishing infection (58). An analysis of the genome of several
Gram-positive bacteria revealed that there is more than one sortase
gene per bacterial genome (54).
In the present report, we have identified and purified an enzyme from
Streptococcus pyogenes that actively cleaves the
LPXTG anchor motif but is very different from the sortase of
S. aureus in its glycosylation and presence of uncommon
amino acids. We here describe the physical and biochemical properties
of this enzyme, which we term LPXTGase.
 |
EXPERIMENTAL PROCEDURES |
Enzymes--
N-Glycosidase F (catalog no. 1,365,193)
and O-glycosidase (catalog no. 1,347,101) were purchased
from Roche Molecular Biochemicals. -N-Acetylhexosaminidase (A7708) and -glucosidase
(G6906) were purchased from Sigma. Group C streptococcal C1 phage lysin
was prepared by the method described by Nelson et al.
(59).
Other Materials--
Silica gel TLC plates (catalog no. M
5729-6), solvents, and other chemicals were purchased from Fisher.
Carboxymethyl glass beads (G-3910) and 1-ethyl-3-(dimethylaminopropyl)
carbodiimide (E-1769) and buffers were purchased from Sigma.
125I was purchased from PerkinElmer Life Sciences.
Bacterial Strain and Culture--
S. pyogenes strain
D471 was grown in 50 liters of Todd-Hewitt medium supplemented with 1%
yeast extract in a fermenter. Cells were harvested when the OD at 650 nm reached 1.0. To harvest the cells, the culture was concentrated to
about 2 liters by means of a Millipore Corp. Procon filtration
apparatus, and the concentrated culture was centrifuged for 10 min at
8,000 rpm using a GSA rotor. Cell pellets (about 120 g total wet
weight) were suspended in 1.5 liters of 30 mM
MES1 buffer, pH 6.2, and the
cells were pelleted again by centrifugation.
Cell Lysis and Preparation of Crude Extract--
The washed cell
pellets described above were suspended in 1.2 liters of 30 mM MES buffer, pH 6.2, and cell clumps were gently dispersed with a Dounce homogenizer. To the cell suspension 10,000 units of lysin, a muralytic enzyme of a group C phage origin (60), were
added, and the mixture was stirred for 1 h at 37 °C. Treatment with a low concentration of lysin resulted in localized digestion of
cell wall peptidoglycan, creating holes in the cell wall. Cell membrane
and cytosol exuded through these holes, releasing cytosol and part of
the cell membrane as vesicles (59, 61). The cell ghosts were pelleted
by centrifugation for 20 min at 10,000 rpm with a GSA rotor, and the
supernatant containing cytosol and membrane vesicles was collected. The
cell ghosts were then resuspended in 600 ml of the MES buffer, the
suspension was centrifuged again, and the supernatant was collected.
The combined supernatant, termed the cytosol fraction, was used as a
starting material for enzyme purification. The cell ghosts, which
retained the remainder of the cell membrane, were suspended in 800 ml
of the MES buffer, and after adding Brij 35 to a final concentration of
0.2%, the mixture was stirred overnight at 4 °C. The mixture was
then centrifuged for 30 min at 10,000 rpm, and the resulting
supernatant, termed the membrane extract, was also used as a starting
material for enzyme preparation.
Preparation of LPXTG Peptide Substrate--
An
LPXTG-containing peptide, KRQLPSTGETANPFY from the
streptococcal M6 protein, was synthesized by the Rockefeller University Peptide Synthesis Laboratory. The C-terminal tyrosine was added to
allow the peptide to be labeled with 125I using IODOBEADs.
Generally, 2 mg of the peptide was labeled with 1 mCi of
125I. The N terminus of the labeled peptide was then linked
to carboxymethyl glass beads by carbodiimide catalysis according to the
manufacturer's instructions. To achieve the linkage, the peptide (1.2 µmol) was incubated for 7 h at 37 °C with 200 mg of the glass
beads (59 µmol of carboxyl termini) and 30 µmol of
1-ethyl-3-(dimethylaminopropyl) carbodiimide with gentle shaking in 2 ml of 100 mM MES buffer, pH 4.9. The reaction mixture was
placed in a small column, and unreacted peptide was removed by washing
the column with 300 ml of 1 M Tris-HCl buffer, pH 8.6, containing 1% SDS, and then with 1 liter of distilled water. Similar
bead-bound peptides in which the LPSTGE was reversed (EGTSPL) or
randomly placed (TEPGSL) were synthesized, labeled, and purified in the
same way.
Purification of LPXTGase--
To about 1.8 liters of the cytosol
fraction, Brij 35 was added to a final concentration of 0.1%, and the
fraction was applied to a DEAE-cellulose column (16 × 4.3 cm)
equilibrated with 20 mM Tris-HCl buffer, pH 6.8. About 500 ml of clear solution absorbing UV at 280 nm eluted first, followed by
turbid UV-absorbing solution. After all of the applied cytosol fraction
entered the column, the column was washed with 20 mM
Tris-HCl buffer, pH 7.6, containing 0.1% Brij 35. The wash step eluted
additional turbid solution and then eluted a clear UV-absorbing
solution. Generally, 500 ml of wash buffer was required until UV
absorbance returned to base line. The column was then eluted with 0.1 M KCl in 20 mM Tris-HCl buffer, pH 7.6, and
0.1% Brij 35 and finally with 0.1 N NaOH. The clear
fall-through eluant was collected and saved while the turbid
fall-through eluant was reapplied to a second DEAE-cellulose column of
similar dimensions, and the clear eluant was collected. The turbid
eluant that followed was applied to a third DEAE-cellulose column, and
the column was eluted in the same manner. The pool of clear eluants
amounting to about 3 liters was concentrated to 30 ml using an Amicon
ultrafiltration apparatus fitted with a YM3 membrane with a 3-kDa
molecular mass cut limit. One-half of the concentrated solution was
applied to a Sephadex G50 column (60 × 4.3 cm) equilibrated with
20 mM Tris-HCl buffer, pH 7.6, containing 0.1% Brij 35;
the column was then eluted with the same buffer solution, and 20-ml
fractions were collected.
Enzyme Assay Method--
Aliquots (10 µl) were removed from
the column fractions and added to 1.5-ml Microfuge tubes. To each tube
was added 30 µl of 40 mM Tris-HCl buffer, pH 7.6, containing 0.1% Brij 35, followed by a 10-µl suspension of
bead-bound LPXTG peptide substrate (0.5-0.8 µg,
100,000-200,000 cpm). The reaction mixture was incubated with vigorous
shaking for 60 min at 37 °C. After this time, 100 µl of water was
added to each tube, and after vortex mixing, the mixture was
centrifuged at 10,000 rpm for 5 min to pellet the beads. 100 µl of
the supernatant was withdrawn, and radioactivity was counted with a counter.
Optimization of Enzyme Activity--
To determine the pH optimum
of enzyme activity, enzyme reactions were carried out under various pH
conditions using the following buffers: MES-NaOH (pH 5, 6, 6.5, and 7),
Tris-HCl (pH 7.5, 8.0, 8.5, and 9), NH4OH-HCl (pH 10), and
triethylamine HCl (pH 11 and 12). To determine the effect of detergents
on enzyme activity, enzyme reactions were carried out in the presence
of 0.05-0.5% of Brij 35 or Triton X-100. To determine the optimal
duration of reaction time, the amount of radioactive peptide released
from the beads was measured at 10-min intervals up to 2 h.
Identification of Enzyme Reaction Products--
About 2 µg of
bead-bound or free KRQLPSTGETANPFY, in which the terminal tyrosine was
labeled with 125I, was incubated with purified LPXTGase in
50 µl of 30 mM Tris-HCl buffer, pH 7.6, containing 0.1%
Brij in separate Microfuge tubes for a varying length of time at
37 °C with vigorous shaking. For reactions with bead-bound peptide,
the tubes were centrifuged at designated times in order to pellet
unreacted bead-bound peptide, and 30-µl aliquots of the supernatant
were spotted onto a silica gel TLC plate. For reaction with free
peptide, 30-µl aliquots from each tube at designated times were
directly spotted on a silica gel TLC plate. The plates were developed
with a solvent mixture consisting of ethyl acetate/pyridine/acetic
acid/water (60:30:9:24), and the reaction products were located by
autoradiography. Reaction products were eluted from the plate, and
amino acid sequences were determined with an Applied Biosystems AB1
Procise 494 instrument by the Rockefeller University protein chemistry laboratory.
Various concentrations of LPXTGase or trypsin (as control) was added to
50 µg of bovine serum albumin (U. S. Biochemical Corp.) under
conditions described above and incubated for 1 h at 37 °C. A
sample of the reaction mixtures was analyzed by SDS-PAGE for degradation.
Enzyme Kinetics--
Varying concentrations of
125I-labeled KRQLPSTGETANPFY peptide, ranging from 20 to
240 µM were incubated with 2.4 µM of the
purified enzyme in 50 µl of 50 mM Tris-HCl buffer, pH
7.6, containing 0.1% Brij 35 at 37 °C for 30 min. At the end of the
reaction time, 30 µl of the reaction mixtures were spotted on silica
gel TLC plates, and the plates were developed with ethyl
acetate/pyridine/acetic acid/water (60:30:9:24). The plates were then
autoradiographed, and substrate and reaction products were scraped off
the plate and counted for radioactivity.
Enzyme Concentration and Dry Weight Determination--
The
fractions with enzyme activity eluting from the Sephadex G50 column
were combined, and the enzyme solution, amounting to about 150 ml, was
concentrated to about 10 ml by YM3 ultrafiltration, after which an
aliquot of 2-3 ml was lyophilized. The lyophilized enzyme was
dissolved in 200 µl of distilled water, and the concentrated enzyme
solution was divided into two preweighed Microfuge tubes. To each tube
300 µl each of ethanol and ethyl acetate was added. The tubes were
kept at 20 °C, precipitating the enzyme, leaving most of the Brij
35 and buffer salts in the supernatant. The precipitated enzyme was
pelleted by centrifugation, and the pellets were dissolved in a small
volume of distilled water. This enzyme solution was used as the
starting material for various chemical analyses. For dry weight
determination, the precipitate was dissolved in 200 µl of distilled
water and the ethanol/ethyl acetate precipitation step was repeated two
more times in order to remove residual detergent and salts, the final
precipitate was dried in vacuo, and the tubes were weighed.
Amino Acid and Sugar Composition of LPXTGase--
The amino acid
and sugar composition of the LPXTGase were determined by the
Rockefeller University Protein Chemistry Laboratory using a Waters 490 HPLC system. The concentrated enzyme in distilled water described above
was used as starting material for these analyses.
Determination of the Amino Acid Sequence of a Tryptic Fragment of
the Enzyme--
To remove covalently bound carbohydrate from the
protein backbone of the LPXTGase, 1.2 mg of the enzyme was incubated
for 36 h at 37 °C with vigorous shaking with 10 units of
N-glycosidase F and 10 milliunits of
O-glycosidase in 600 µl of 30 mM Hepes buffer,
pH 7.6, containing 0.1% Brij 35 in a Microfuge tube. The incubation
mixture was then banded on silica gel plates, and the plates were
developed twice with 80% ethanol. The deglycosylated protein band was
visualized by exposing the plate to iodine vapor. The protein band was
eluted with 80% ethanol and concentrated to about 200 µl in a
Speedvac (Savant). To the concentrated protein solution, 400 µl of 30 mM Hepes buffer, pH 7.6, containing 0.1% Brij 35, and 5 µg of trypsin were added, and the mixture was incubated overnight at
37 °C. To prepare phenylthiohydantoin (PTH)-labeled tryptic
fragments, 3 µl of phenylisothiocyanate, and 300 µl of pyridine
were added to the trypsinized enzyme, after which a small volume of 1 N NaOH was added to raise the pH to 9, and the mixture was
shaken at 37 °C for 6 h. The reaction mixture was then banded on a silica gel plate and developed with a solvent mixture consisting of n-butyl alcohol, hexane, acetic acid, and water
(40:40:9:1).
UV-absorbing, PTH-labeled tryptic fragments were located, and the
fragments were eluted with 95% ethanol. The slow moving fragment was
then subjected to Edman degradation as follows. After hydrolysis of the
PTH-peptide by a 30-min exposure to 30% trifluoroacetic acid at
50 °C, the PTH-derivative and residual peptide were separated on a silica gel TLC plate using the same running solvent. The PTH-derivative was located under a UV light, and the residual peptide
was located by exposure of the plate to iodine vapor. In this manner,
seven PTH-derivatives were prepared. The Rockefeller University Protein
Chemistry Laboratory identified the PTH-derivatives. Of the seven
PTH-derivatives, four exhibited unusual masses. To help identify them,
these derivatives were acid-hydrolyzed, and the Protein Chemistry
Service Laboratory again analyzed the resulting products.
Inactivation of LPXTGase by Glycosidases--
LPXTGase was
preincubated with glycosidases in 40 µl of 30 mM Tris-HCl
buffer, pH 7.6, containing 0.1% Brij 35, for 1 h at 37 °C,
after which a 10-µl suspension of bead-bound,
125I-labeled KRQLPSTGETANPFY peptide was added, and the
reaction mixture was incubated for 1 h. At the end of the
incubation, peptide cleavage was determined as described above.
Radiolabeling the LPXTGase--
To label the LPXTGase directly
for visualization on SDS gels, 125I-tyramine was linked to
the enzyme. Tyramine (1 µmol) was incubated for 5 h at 37 °C
with 20 µCi of 125I in the presence of IODOBEADs in 200 µl of 20 mM phosphate buffer, pH 6.5. 30 µl of the
125I-labeled tyramine solution was transferred to a
Microfuge tube, to which were added about 60 µg of concentrated
LPXTGase and 50 µg of 1-ethyl-3-(dimethylaminopropyl) carbodiimide,
both in 50 µl of distilled water, and then 20 µl of 1 M
MES buffer, pH 4.9, and 2 µl of 10% Brij 35 were added. Finally,
distilled water was added to bring the volume of the incubation mixture
to 200 µl, and the mixture was incubated for 7 h at 37 °C
with gentle shaking. At the end of the incubation, the volume of the
incubation mixture was reduced to 50 µl by means of a Speedvac, and
the enzyme was precipitated with ethanol and ethyl acetate as described above.
 |
RESULTS |
Purification of the LPXTGase--
Using the bead-bound
125I-labeled KRQLPSTGETANPFY peptide from S. pyogenes, which contains the LPXTG motif, we attempted
to identify an endopeptidase in the streptococcal cell extract. In
numerous initial trials, no LPXTG cleavage activity was
detected in any crude fraction or in fractions from chromatography
columns. Eventually, we discovered that ultrafiltrates of the crude
extract using a YM3 filter removed a low molecular weight substance
that inhibited the cleavage activity. After removing this inhibitor by
ultrafiltration, active enzyme could be prepared from both cytosol and
membrane extracts. The enzyme activity in the cytosol is entirely
attributable to membrane vesicles released into the cytosol rather than
a soluble cytosol fraction. For example, lysin treatment of S. pyogenes results in localized digestion of the cell wall,
producing holes in the cell wall. Through these holes, segments of cell
membrane exude externally, which become pinched off as vesicles (59). When the turbid cytosol was centrifuged for 1 h at 30,000 rpm, membrane vesicles along with all of the enzyme activity were pelleted. A large part of the cell membrane still remained associated with the
cell ghosts, and more cleavage activity could be extracted from the
ghost-associated membranes.
Preliminary experiments revealed that LPXTG cleavage
activity does not bind to DEAE-cellulose, whereas most proteins did. Thus, the cytosol fraction containing membrane vesicles or the membrane
extract of the cell ghost was directly applied to a DEAE-cellulose column as the first step of enzyme preparation. Free enzyme released from the membrane eluted first in the clear fall-through fraction, which was followed by the vesicle-containing turbid fraction. However,
neither the clear nor turbid fall-through fractions showed an
LPXTG cleavage activity initially (Fig.
1). Thus, when the volume of the clear
fall-through fraction was reduced by ultrafiltration using a 3-kDa
cut-off YM3 membrane, the retentate exhibited enzyme activity. This
suggests that a low molecular weight inhibitor eluted from the DEAE
column together with the enzyme in the fall-through fraction, and the
inhibitor passed through the membrane during ultrafiltration. As the
concentration of Brij 35 in the fall-through fraction increased during
concentration, it formed micelles, which could not pass through YM3
membrane, and as a consequence the retentate became very viscous.
Therefore, to remove Brij 35, a large volume of detergent-free Tris-HCl
buffer was added to the retentate, and the ultrafiltration process was
continued. During this procedure, more of the enzyme inhibitor passed
through the YM3 membrane along with monomeric Brij 35, increasing the
activity of the enzyme in the retentate.

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 1.
DEAE-cellulose chromatography of the cytosol
fraction. The cytosol fraction containing membrane vesicles was
chromatographed on a DEAE-cellulose column as described under
"Experimental Procedures." Aliquots (10 µl) of fractions were
assayed for cleavage activity of bead-bound 125I-labeled
LPXTG-containing peptide as described under "Experimental
Procedures." The solution eluting from the column in the fractions
appeared clear and turbid.
|
|
When the concentrated enzyme solution was subjected to gel filtration
using Sephadex G50, an active enzyme peak eluted soon after the void
volume (Fig. 2). The activity peak did
not absorb UV at 280 nm, indicating that the enzyme does not contain
aromatic amino acids. Comparison with the elution profiles of proteins of known molecular weights indicates that the apparent molecular weight
of the cleavage enzyme is about 14,000.

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 2.
Chromatography on Sephadex G50 of the clear
fall-through material from the DEAE-cellulose column. The clear
fall-through fractions eluting from the DEAE-cellulose column in Fig. 1
were pooled and concentrated by means of ultrafiltration. The
concentrated enzyme solution was subjected to gel filtration on a
Sephadex G50 column, and aliquots (10 µl) of fractions from the
column were assayed for cleavage activity of bead-bound
125I-labeled LPXTG-containing peptide as
described under "Experimental Procedures."
|
|
SDS-PAGE analysis revealed no protein bands stained with either
Coomassie Blue or silver, even when over 100 µg of the purified enzyme was applied to a 16% gel (not shown). However, the lack of
protein bands verified the purity of the enzyme preparation. Thus, in
order to detect the enzyme in polyacrylamide gels,
125I-labeled tyramine was linked to the carboxyl groups of
the enzyme by means of carbodiimide catalysis, and the radioactive
enzyme was subjected to SDS-PAGE. Autoradiography of dried gels showed that most of the labeled enzyme was retained in the stacking gel, and
only a small amount entered the running gel (Fig.
3). When the enzyme was labeled with
fluorescein isothiocyanate and subjected to SDS-PAGE, most of the
fluorescent enzyme was located in the stacking gel, with a small amount
entering the running gel as a series of faint bands, forming a ladder
(not shown) with no fluorescent material at the 14-kDa region. These
observations strongly suggest that the enzyme forms large aggregates in
the presence of SDS.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 3.
SDS-PAGE analysis of the
125I-labeled LPXTGase. The ethanol and ethyl
acetate-precipitated enzyme that had been labeled with
125I-tyramine was solubilized in 0.2% SDS in 100 mM Tris-HCl buffer, pH 6.8, and after boiling, the enzyme
was subjected to SDS-PAGE using 16% acrylamide gel, and the dried gel
was autoradiographed.
|
|
Enzyme Reaction Products--
To determine where in the
LPXTG motif cleavage occurred, purified endopeptidase was
used to cleave a bead-bound form of the KRQLPSTGETANPFY peptide, and
the cleaved fragment was subjected to N-terminal sequence analysis.
Results revealed that the enzyme cleaved after glutamic acid within the
LPSTGE sequence, releasing the TANPFY peptide fragment (Fig.
4A). On the other hand, the enzyme cleaved the free KRQLPSTGETANPFY peptide at two sites, after the
serine and the glutamic acid of LPSTGE, yielding TGETANPFY and TANPFY,
respectively (Fig. 4B). The fact that only these products were observed indicates that the trypsin (KR) and chymotrypsin (FY)
substrates found at either end of the peptide were not cleaved by the
endopeptidase. When the enzyme was reacted with similar bead-bound
peptides in which the LPSTGE was reversed (EGTSPL) or randomly placed
(TEPGSL), no cleavage was observed (not shown). No cleavage was also
observed when native bovine serum albumin was reacted in a similar way.
The small amount of radioactive materials observed at the solvent front
originated from the impurities in the synthetic peptide. These
impurities were not reactive to enzyme action. Based on its ability to
specifically cleave within the LPXTG anchor motif of surface
proteins, we have termed this endopeptidase "LPXTGase."

View larger version (69K):
[in this window]
[in a new window]
|
Fig. 4.
Cleavage of an LPXTG peptide
by LPXTGase. A, bead-bound KRQLPSTGETANPFY, in which
the C-terminal tyrosine was labeled with 125I, was
incubated with purified LPXTGase, and the reaction product was examined
on silica gel TLC as described under "Experimental Procedures."
B, free KRQLPSTGETANPFY, in which the C-terminal tyrosine
was labeled with 125I, was incubated with purified
LPXTGase, and the reaction products were examined on silica gel TLC as
described under "Experimental Procedures." Y, the
location of free tyrosine. The locations of other peptide sequences
were identified after sequencing the peptide within their respective
spots.
|
|
Enzyme Kinetics--
Since the enzyme does not contain any
aromatic amino acid, neither the Lowry nor Bradford methods could be
used to determine protein concentration. Thus, the enzyme concentration
was determined on the basis of its estimated molecular mass (14 kDa) and dry weight. Using this, a Lineweaver-Burk plot of the kinetics
of the LPXTGase was determined (Fig. 5),
resulting in a Km of 0.26 mM and a
Vmax of 67 µM in 30 min when 2.4 µM enzyme was used in the assay.

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 5.
The kinetics of cleavage of
LPXTG peptide by LPXTGase.
125I-Labeled KRQLPSTGETANPFY, ranging from 20 to 240 µM, was incubated for 30 min with 2.4 µM
LPXTGase, and the kinetics of cleavage of the peptide was determined as
described under "Experimental Procedures."
|
|
Optimal Conditions for Enzyme Activity--
As shown in Fig.
6, the LPXTGase exhibited a broad pH
optimum between 7.5 and 10. Below pH 5 or above 10, the enzyme activity could not be measured. In most enzyme assays, pH 7.6 was used, because
background activity was higher at higher pH. Enzyme activity was
highest when 0.1-0.2% of both Brij 35 and Triton X-100 was incorporated. The maximal initial enzyme velocity was maintained up to
the first 20 min, and after 1 h only small additional cleavage of
the peptide occurred.

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 6.
pH optimum of LPXTGase activity. The
optimum pH for LPXTGase activity was determined, at 50 mM
concentrations of various buffers. The buffers employed were as
follows: MES-NaOH for pH 5, 5.5, 6, 6.5, and 7; Tris-HCl for pH 7.5, 8, 8.5, and 9; NH4OH-HCl for pH 10; and triethylamine HCl for
pH 11 and 12.
|
|
Inhibition of Activity by Salts--
The LPXTGase was exposed to a
variety of salts, and its activity was tested for cleavage of the
LPXTG-containing peptide. As seen in Table
I, the enzyme was found to be rather
sensitive to exposure to a number of certain salts.
View this table:
[in this window]
[in a new window]
|
Table I
Effect of salts on LPXTGase activity
Reaction mixtures contained, in 50 µl of 40 mM Tris-HCl,
pH 7.6, and 0.1% Brij 35, a fixed amount of LPXTGase,
125I-labeled LPXTG-peptide (about 180,000 cpm), and the
indicated concentrations of various salts. The reaction mixtures were
incubated for 1 h at 37 °C, and the peptide cleavage was
determined as described under "Experimental Procedures."
|
|
Presence of Carbohydrate in the LPXTGase--
Successful linking
of 125I-labeled tyramine to the enzyme demonstrated that it
possesses free carboxyl groups. Nonetheless, the enzyme did not bind to
DEAE-cellulose, indicating that these carboxyl groups are not
surface-exposed. It seemed plausible that the charged amino acids of
the enzyme are internalized and that the hydrophobic amino acids
are located on the exterior surface in view of the fact that the enzyme
is likely to be associated with the cell membrane. However, an enzyme
with a hydrophobic surface would not be very soluble in aqueous buffer,
which is contrary to our findings. This suggested to us that a few
residues of sugars, which would prevent surface exposure of the
carboxyl groups but would confer surface hydrophilicity to the enzyme,
might shield the carboxyl groups, allowing them to remain soluble in
aqueous buffer. To test this, the enzyme was incubated with 5 mM of periodate in 20 mM phosphate buffer, pH
6, for 4 h at 4 °C, and enzyme activity was measured. We found
that this treatment nearly completely abolished the enzyme activity,
whereas periodate treatment of trypsin in an identical manner showed no
effect on its enzyme activity.
When the sugar composition of the LPXTGase was analyzed, we found
L-fucose, D-galactose,
D-galactosamine, D-glucose,
D-glucosamine, and D-mannose in a molar ratio
of 1:2:3:13:2:2 (Fig. 7). The aggregate mass of the oligosaccharide is 3,936 daltons. In addition, we found an
unidentified sugar that had the shortest retention time from the
analytical column. The mass of this unknown sugar residue is estimated
to be about 1 kDa. To determine the carbohydrate linkage that is
necessary for activity, the LPXTGase was preincubated with a number of
glycosidases, prior to testing for endopeptidase activity. As shown in
Fig. 8,
N-acetylhexosaminidase, -glucosidase, and -mannosidase
abolished the LPXTGase activity, but -galactosidase had no effect.
In addition, N-glycosidase F, which cleaves the bond between
asparagine and oligosaccharides, abolished the endopeptidase activity,
but O-glycosidase, which cleaves serine- or threonine-linked oligosaccharide, showed no effect (results not shown). Together, these
results indicate that the carbohydrates linked to the LPXTGase are
essential for catalytic activity.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 7.
Carbohydrate composition of LPXTGase.
The carbohydrate composition of purified LPXTGase was determined by the
Rockefeller University Analytical Service Laboratory using a Waters 490 HPLC system.
|
|

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 8.
Inactivation of LPXTGase activity by
glycosidases. A fixed amount of LPXTGase was preincubated for
1 h with varying amounts of glycosidases at 37 °C in a 40-µl
reaction volume of 30 mM Tris-HCl, pH 7.6, containing 0.1%
Brij 35. At this time, 10 µl of 125I-labeled, bead-bound
LPXTG peptide substrate (about 180,000 cpm) was added, the
mixture was incubated at 37 °C for an additional 1 h, and
the radioactivity of the cleaved peptide fragment was
determined. Triangle, -galactosidase;
square, N-acetylhexosaminidase;
diamond, -glucosidase.
|
|
Amino Acid Composition of LPXTGase--
Amino acid composition of
the purified enzyme revealed 61 amino acid residues with an aggregate
mass of 6,306 daltons (Table II). The
enzyme contains only 11 amino acid species and no aromatic amino acid,
which explains the failure of the enzyme to absorb UV at 280 nm and the
failure to be stained by Coomassie Blue. Interestingly, the enzyme
contains only a few hydrophobic amino acids but an unusually large
number of alanines. A most striking feature is the presence of unusual
(unknown) amino acids, with an aggregate mass of about 3,000 daltons,
or about 30% of the enzyme's protein backbone. The unusual
hydrophobicity of the enzyme appears to be imparted by these unknown
amino acids, as will be discussed below.
View this table:
[in this window]
[in a new window]
|
Table II
Amino acid composition of LPXTGase
The amino acid composition of LPXTGase was determined by the
Rockefeller University Protein Chemistry Laboratory.
|
|
Amino Acid Sequence of a Tryptic Fragment of the
LPXTGase--
Despite its purity, several attempts to determine the
amino acid sequence of the enzyme using an automated sequencer were unsuccessful, even when efforts were made to sequence the
deglycosylated core protein. Because this suggested that the N terminus
might be blocked, we attempted to sequence an internal tryptic fragment of the core protein, also without success.
The sequence failure suggested either that the standard program used
for automated sequencing could not be applied to this peptide or that
the sequence was made up of unusual amino acids. Thus, we elected to
sequence an internal fragment manually. For this purpose, the enzyme
was first treated with N-glycosidase F and
O-glycosidase, and the deglycosylated core protein was
separated on silica gel TLC (Fig.
9A). When 80% ethanol was
used as the running solvent, the core protein moved with an
RF of 0.6, which was closely followed by Hepes
buffer, while the carbohydrate remained at the origin. Under identical
TLC conditions, untreated enzyme, bovine serum albumin, ovalbumin, and
trypsin remained at the origin (not shown). The high
RF value of the core protein verifies its high
hydrophobicity. The core protein was then digested with trypsin, and
the digestion products were incubated with phenylisothiocyanate in
order to produce PTH-peptides as described under "Experimental
Procedures." The reaction products were separated on a silica gel TLC
plate using n-butyl alcohol/hexane/acetic acid/water
(40:40:9:1) as the running solvent. As shown Fig. 9B, two
PTH-peptides were detected. Very faint UV-absorbing material remained
at the origin, which is attributable to PTH-trypsin. Under identical
TLC conditions, PTH-bovine serum albumin and PTH-trypsin also remained
at the origin. The mobility of these PTH-peptides in the highly
nonpolar solvent further verified the unusual hydrophobicity of the
peptides. The slow moving fragment was then subjected to Edman
degradation, and seven PTH-derivatives were obtained as described under
"Experimental Procedures." Using a C-18 column, both the first and
the second PTH-derivatives were identified to be PTH-proline, and the
seventh was identified as PTH-aspartic acid/asparagine. But the third,
fourth, fifth, and sixth PTH-derivatives exhibited retention times far
longer than those of any known PTH-derivatives. The masses of
these PTH-derivatives were 537.0, 537.0, 212.1, and 288.0 Da
respectively, which do not match with the total mass of known
PTH-derivatives.

View larger version (151K):
[in this window]
[in a new window]
|
Fig. 9.
Purification of the core protein of LPXTGase
and separation of the phenlthiohydantoin-labeled tryp- tic
fragments of the core protein. A, the LPXTGase was
deglycosylated as described under "Experimental Procedures," and
the core protein and carbohydrates were separated on silica gel TLC
using 80% ethanol as a running solvent. B, the
deglycosylated enzyme (core protein) was eluted from the plate and
subjected to trypsin digestion, and the N termini of the tryptic
fragments were linked to PTH as described under "Experimental
Procedures." The PTH-labeled tryptic fragments were separated on
silica gel TLC using a solvent mixture consisting of n-butyl
alcohol, hexane, acetic acid, and water (40:40:9:1).
|
|
Because of their high total mass, the possibility that the third and
the fourth amino acids were covalently linked to an unknown molecule
was considered. Therefore, the third PTH-derivative was acid-hydrolyzed
with 6 N HCl for 22 h at 110 °C, and the products were analyzed by a C-18 reverse phase column (Fig.
10A) and mass spectroscopy
(Fig. 10B). Whereas the reverse phase column chromatography revealed a single PTH-compound, with a retention time close to that for
PTH-phenylalanine, the mass spectroscopy showed three distinct
peaks with masses of 102.2, 288.1, and 519.2 Da, which do not
correspond with those of known PTH-derivatives. Acid hydrolysis of the
fourth PTH-derivative gave rise to identical results as the third
PTH-derivative. Meanwhile, the acid hydrolysate of the fifth
PTH-derivative contained two species with masses of 102.1 and 212.1, the latter representing unhydrolyzed material. Acid hydrolysate of the
sixth PTH-derivative contained two species with masses of 102.1 and
288.0, the latter also representing the unhydrolyzed material. Thus, we
could only conclude from the species generated by acid hydrolysis that
the third, fourth, fifth, and sixth PTH-derivatives are not common
amino acids.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 10.
Analysis of an unusual amino acid present in
peptide fragment 1. The third PTH-derivative of tryptic fragment
1, exhibiting a mass of 537.0, was hydrolyzed for 22 h with 6 N HCl at 110 °C, and the hydrolysis products were
examined with reverse phase chromatography (A) and mass
spectroscopy (B).
|
|
 |
DISCUSSION |
The LPXTGase of S. pyogenes is an unusual enzyme in
many respects. The enzyme is glycosylated, and the carbohydrate moiety appears to be essential for enzyme activity. This suggests that a
certain spatial arrangement of carbohydrate and protein backbone is
necessary for enzyme activity. As far as we know, no precedent for a
glycosylated enzyme exists in prokaryotes. However, in eukaryotes, C1r
and C1s, the subcomponents of the complement C1, and prekallikrein, a
protease in the blood clotting cascade, are known to be glycosylated (62, 63). It is not known whether these carbohydrates play any role in
the proteolytic reaction.
In the LPXTGase, the protein backbone is extremely hydrophobic, which
may be attributed to the presence of uncommon amino acids. This is
supported by the fact that the PTH-compounds of these unusual amino
acids moved nearly to the solvent front with a running solvent mixture
of n-butyl alcohol/hexane/acetic acid/water (40:40:9:1). Seven lysine residues were found in the enzyme, yet tryptic digestion of the enzyme yielded only two fragments, indicating that either several lysine residues were not accessible to trypsin or
that some lysines were modified. It is tempting to speculate that in
living bacteria, the hydrophobic protein backbone is embedded in the
cell membrane and that the hydrophilic carbohydrate is localized within
the hydrophilic peptidoglycan layer. The salt sensitivity of the
LPXTGase activity probably reflects an intimate association of the
enzyme with the hydrophobic environment of membrane.
Direct determination of the purity of the purified LPXTGase by standard
procedures such as SDS-PAGE analysis was not possible because of its
ability to form large aggregates in the presence of SDS, and as a
result it is unable to enter the resolving gel as a distinct protein
band and barely enters the 4% stacking gel. The protein does not
contain any aromatic amino acids, which explains its inability to
absorb UV at 280 nm, and does not stain with Coomassie Blue or silver.
Even when over 200 µg of purified enzyme was subjected to SDS-PAGE,
no protein band was detected after staining with Coomassie Blue or
silver, indicating that the purified enzyme sample did not contain any
stainable protein contaminant. We considered that the observed LPXTGase
activity might be attributed to a very small amount of contaminant
rather than the glycoprotein that we have identified. However, if this
were true, we must conclude that the putative contaminant with
endopeptidase activity is also a glycoprotein, because removal of
sugars from purified endopeptidase preparations always abolished the
enzyme activity.
Over the course of these studies, several independently purified
LPXTGase samples were analyzed for amino acid sequence. In each
analysis, 200 µg to over 1 mg dry weight of the enzyme sample was
used. Since as little as a 0.1-µg sample of a 10-kDa peptide is
sufficient for sequencing by the automated sequencer, 0.01-0.05% of
contaminating proteins would have been detected by the instrument. In
fact, 10 of our most purified samples could not be sequenced, and no
false sequence data could be obtained, further verifying the purity of
the preparation.
In contrast to the sortase described by Schneewind et al.
(55), which cleaves the LPXTG sequence after threonine, our
LPXTGase cleaves the bead-bound KRQLPSTGETANPFY after glutamic acid and cleaves the free form of the same pentadecapeptide after both serine
and glutamic acid. In contrast to sortase, our LPXTGase does not have
cysteine or methionine and is totally insensitive to sulfhydryl
reagents. Another difference between LPXTGase and sortase is that
hydroxylamine inhibits the activity of our LPXTGase, whereas
hydroxylamine stimulates the activity of sortase. The LPXTGase activity
was reduced by more than 70% in the presence of 100 mM
hydroxylamine, and it was completely abolished in the presence of 200 mM.
Another clear distinction between sortase and LPXTGase lies in the
substrate cleavage activities of the enzymes. The Km value of 0.26 mM for LPXTGase for the KRQLPSTGETANPFY
peptide was comparable with the reported Km values
of 0.21, 0.36-3.1, and 0.08-0.5 mM for human Lys-plasmin
(64), bovine trypsin (65), and a protease from S. aureus,
respectively (66), for synthetic peptides. The calculated turnover
value, or Kcat, of the LPXTGase is 0.016/s. In
comparison, the reported Kcat values for bovine trypsin ranged from 0.003 to 1.35/s, depending on the synthetic substrate used (65). When compared with the calculated
Kcat of sortase from S. aureus (56),
the 0.016/s Kcat value of LPXTGase from S. pyogenes is at least 2 orders of magnitude higher. It is estimated
that there are at least five different surface proteins on a given
Gram-positive bacterium that are anchored through the LPXTG
motif, and there are probably thousands of copies of these molecules
expressed in each organism. Thus, in order to properly anchor all these
molecules during the 30-40-min division time of the bacterial cell, an
enzyme with a high Kcat would be necessary to
successfully accomplish this.
Many peptide antibiotics produced by Bacillus sp. contain
unusual amino acids, and these peptides are synthesized nonribosomally on amino acid-activating polyenzyme templates. The overrepetition of
alanine in the LPXTGase seems unusual; however, another characteristic of nonribosomally synthesized peptides is the overrepetition of some
amino acids. For example, tyrocidine, a cyclic decapeptide antibiotic
from Bacillus brevis, contains ornithine and three phenylalanines, two of which are in the D-configuration.
The mechanism of nonribosomal peptide synthesis was most extensively
investigated previously in the synthesis of tyrocidine (67-70).
Recently, the genes encoding the polyenzymes of tyrocidine synthesis
have been cloned (71).
It is surprising that S. pyogenes produces a small molecule
that inhibits the activity of LPXTGase. We speculate that such an
inhibitor may have some important regulatory function in the living
bacterial cell. This is supported by the fact that S. pyogenes grown in the presence of this inhibitor fails to display
M protein and fibronectin-binding protein on the cell
surface,2 suggesting that the
function of this LPXTGase may be essential for cell surface expression
of these proteins. Another important question is whether the LPXTGase
and its inhibitor are present in other Gram-positive bacteria. When one
assumes that surface proteins in most Gram-positive bacteria become
anchored to cell wall peptidoglycan by a common mechanism, it is likely
that the answer is yes. This has been verified from our recent finding that S. aureus also produces an enzyme strikingly similar to
the LPXTGase of S. pyogenes. The S. aureus enzyme
cleaves the LPXTG motif, has a similar molecular weight, and
is glycosylated like the S. pyogenes
enzyme.3 In addition, we
found a low molecular weight inhibitor from S. aureus that
inhibits both the activity of this enzyme and the LPXTGase from
S. pyogenes. An interesting possibility exists, therefore,
that analogues of LPXTGase and sortase are present in all Gram-positive
bacteria and that these two enzymes function together to accomplish the
cleavage of the LPXTG motif of surface proteins and the
ultimate anchoring of the cleaved protein to the cell wall. Precisely
how these two enzymes accomplish this is currently being investigated.
 |
ACKNOWLEDGEMENTS |
We thank Peter Model and Emil Gotschlich for
useful suggestions after reading the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by a grant from SIGA
Technologies and United States Public Health Service Grant AI11822 (to V. A. F.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 212-327- 8166;
Fax: 212-327-7584; E-mail: vaf@rockefeller.edu or leesu{at}rockefeller.edu.
Published, JBC Papers in Press, October 4, 2002, DOI 10.1074/jbc.M208660200
2
S. Lee and V. A. Fischetti, manuscript in preparation.
3
S. Lee and V. A. Fischetti, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
MES, 4-morpholineethanesulfonic acid;
HPLC, high pressure liquid
chromatography;
PTH, phenylthiohydantoin.
 |
REFERENCES |
| 1.
|
Patti, J. M.,
Allen, B. L.,
McGavin, M. J.,
and Hook, M.
(1994)
Annu. Rev. Microbiol.
48,
585-617[Medline]
[Order article via Infotrieve]
|
| 2.
|
Courtney, H. S.,
Bronze, M. S.,
Dale, J. B.,
and Hasty, D. L.
(1994)
Infect. Immun.
62,
4868-4873[Abstract/Free Full Text]
|
| 3.
|
Wang, J.-R.,
and Stinson, M. W.
(1994)
Infect. Immun.
62,
442-448[Abstract/Free Full Text]
|
| 4.
|
Berkower, C.,
Ravins, M.,
Moses, A. E.,
and Hanski, E.
(1999)
Mol. Microbiol.
31,
1463-1475[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Hanski, E.,
and Caparon, M.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
6172-6176[Abstract/Free Full Text]
|
| 6.
|
Talay, S. R.,
Valentin-Weigand, P.,
Timmis, K. N.,
and Chhatwal, G. S.
(1994)
Mol. Microbiol.
13,
531-539[Medline]
[Order article via Infotrieve]
|
| 7.
|
Kanzaki, H.,
and Arata, J.
(1992)
J. Dermatol. Sci.
4,
87-94[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Signas, C.,
Raucci, G.,
Jonsson, K.,
Lindgren, P.,
Anantharamaiah, G. M.,
Hook, M.,
and Lindberg, M.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
699-703[Abstract/Free Full Text]
|
| 9.
|
Rice, K.,
Huesca, M.,
Vaz, D.,
and McGavin, M. J.
(2001)
Infect. Immun.
69,
3791-3799[Abstract/Free Full Text]
|
| 10.
|
Patti, J. M.,
Bremell, T.,
Krajewska-Pietrasik, D.,
Abdelnour, A.,
Tarkowski, A.,
Ryden, C.,
and Hook, M.
(1994)
Infect. Immun.
62,
152-161[Abstract/Free Full Text]
|
| 11.
|
Switalski, L. M.,
Patti, J. M.,
Butcher, W.,
Gristina, A. G.,
Speziale, P.,
and Hook, M.
(1993)
Mol. Microbiol.
7,
99-107[Medline]
[Order article via Infotrieve]
|
| 12.
|
Patti, J. M.,
Jonsson, H.,
Guss, B.,
Switalski, L. M.,
Wiberg, K.,
Lindberg, M.,
and Hook, M.
(1992)
J. Biol. Chem.
267,
4766-4772[Abstract/Free Full Text]
|
| 13.
|
Tung, H.,
Guss, B.,
Hellman, U.,
Persson, L.,
Rubin, K.,
and Ryden, C.
(2000)
Biochem. J.
345,
611-619
|
| 14.
|
Sinha, B.,
Francois, P.,
Que, Y. A.,
Hussain, M.,
Heilmann, C.,
Moreillon, P.,
Lew, D.,
Krause, K. H.,
Peters, G.,
and Herrmann, M.
(2000)
Infect. Immun.
68,
6871-6878[Abstract/Free Full Text]
|
| 15.
|
Molinari, G.,
Talay, S. R.,
Valentin-Weigand, P.,
Rohde, M.,
and Chhatwal, G. S.
(1998)
Infect. Immun.
65,
1357-1363[Abstract]
|
| 16.
|
Fowler, T.,
Wann, E. R.,
Joh, D.,
Johansson, S.,
Foster, T. J.,
and Hook, M.
(2000)
Eur. J. Cell Biol.
79,
672-679[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Rankin, S.,
Isberg, R. R.,
and Leong, J. M.
(1992)
Infect. Immun.
60,
3909-3912[Abstract/Free Full Text]
|
| 18.
|
Ozeri, V.,
Rosenshine, I.,
Mosher, D. F.,
Fassler, R.,
and Hanski, E.
(1998)
Mol. Microbiol.
30,
625-637[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Sinha, B.,
Francois, P. P.,
Nusse, O.,
Foti, M.,
Hartford, O. M.,
Vaudaux, P.,
Foster, T. J.,
Lew, D. P.,
Herrmann, M.,
and Krause, K. H.
(1999)
Cell Microbiol.
1,
101-117[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Cue, D.,
Dombek, P. E.,
Lam, H.,
and Cleary, P. P.
(1998)
Infect. Immun.
66,
4593-4601[Abstract/Free Full Text]
|
| 21.
|
Cue, D.,
Southern, S. O.,
Southern, P. J.,
Prabhakar, J.,
Lorelli, W.,
Smallheer, J. M.,
Mousa, S. A.,
and Cleary, P. P.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
2858-2863[Abstract/Free Full Text]
|
| 22.
|
Okada, N.,
Liszewski, M. K.,
Atkinson, J. P.,
and Caparon, M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
2489-2493[Abstract/Free Full Text]
|
| 23.
|
Jenkinson, H. F.,
and Demuth, D. R.
(1997)
Mol. Microbiol.
23,
183-190[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Murakami, Y.,
Yamashita, Y.,
Nakano, Y.,
Ito, H. O., Yu, H.,
and Koga, T.
(1997)
Infect. Immun.
65,
1531-1535[Abstract]
|
| 25.
|
Yeung, M. K.,
Donkersloot, J. A.,
Cisar, J. O.,
and Ragsdale, P. A.
(1998)
Infect. Immun.
66,
1482-1491[Abstract/Free Full Text]
|
| 26.
|
Lecuit, M.,
Ohayon, H.,
Braun, L.,
Mengaud, J.,
and Cossart, P.
(1997)
Infect. Immun.
65,
5309-5319[Abstract]
|
| 27.
|
Dramsi, S.,
Dehoux, P.,
Lebrun, M.,
Goossens, P. L.,
and Cossart, P.
(1998)
Infect. Immun.
65,
1615-1625[Abstract]
|
| 28.
|
Pangburn, M. K.,
Schreiber, R. D.,
and Muller-Eberhard, H. J.
(1977)
J. Exp. Med.
146,
257-270[Abstract/Free Full Text]
|
| 29.
|
Igarashi, T.,
Yamamoto, A.,
and Goto, N.
(1995)
Microbiol. Immunol.
39,
853-860[Medline]
[Order article via Infotrieve]
|
| 30.
|
Fischetti, V. A.,
Horstmann, R. D.,
and Pancholi, V.
(1995)
Infect. Immun.
63,
149-153[Abstract]
|
| 31.
| Johnsson, E., Thern, A., Dahlback, B., Heden, L.-O., Wikstrom, M., and
Lindahl, G. (1996) J. Immunol. 3021-3029
|
| 32.
|
Fujita, T.,
Gigli, I.,
and Nussenzweig, V.
(1978)
J. Exp. Med.
148,
1044-1051[Abstract/Free Full Text]
|
| 33.
|
Gigli, I.,
Fujita, T.,
and Nussenzweig, V.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
6596-6600[Abstract/Free Full Text]
|
| 34.
|
Dave, S.,
Brooks-Walter, A.,
Pangburn, M. K.,
and McDaniel, L. S.
(2001)
Infect. Immun.
69,
3435-3437[Abstract/Free Full Text]
|
| 35.
|
Chen, C. C.,
and Cleary, P. P.
(1990)
J. Biol. Chem.
265,
3161-3167[Abstract/Free Full Text]
|
| 36.
|
Wexler, D. E.,
and Cleary, P. P.
(1985)
Infect. Immun.
50,
757-764[Abstract/Free Full Text]
|
| 37.
|
Snyderman, R.,
Phillips, J. K.,
and Mergenhagen, S. E.
(1971)
J. Exp. Med.
134,
1131-1143[Abstract]
|
| 38.
|
Angel, C. S.,
Ruzek, M.,
and Hostetter, M. K.
(1994)
J. Infect. Dis.
170,
600-608[Medline]
[Order article via Infotrieve]
|
| 39.
|
Wani, J. H.,
Gilbert, J. V.,
Plaut, A. G.,
and Weiser, J. N.
(1996)
Infect. Immun.
64,
3967-3974[Abstract]
|
| 40.
|
Kett, K.,
Brandtzaeg, P.,
Radl, J.,
and Haaijman, J. J.
(1986)
J. Immunol.
136,
3631-3635[Abstract]
|
| 41.
|
Berry, A. M.,
Lock, R. A.,
Thomas, S. M.,
Rajan, D. P.,
Hansman, D.,
and Paton, J. C.
(1994)
Infect. Immun.
62,
1101-1108[Abstract/Free Full Text]
|
| 42.
|
Berry, A. M.,
Lock, R. A.,
and Paton, J. C.
(1996)
J. Bacteriol.
178,
4854-4860[Abstract/Free Full Text]
|
| 43.
|
Clarke, V. A.,
Platt, N.,
and Butters, T. D.
(1995)
J. Biol. Chem.
270,
8805-8814[Abstract/Free Full Text]
|
| 44.
|
Zahner, D.,
and Hakenbeck, R.
(2000)
J. Bacteriol.
182,
5919-5921[Abstract/Free Full Text]
|
| 45.
|
Siezen, R. J.
(1999)
Antonie Leeuwenhoek
76,
139-155
|
| 46.
|
Kunji, E. R.,
Mierau, I.,
Hagting, A.,
Poolman, B.,
and Konings, W. N.
(1996)
Antonie Leeuwenhoek
70,
187-221
|
| 47.
|
Fernandez-Espla, M. D.,
Garault, P.,
Monnet, V.,
and Rul, F.
(2000)
Appl. Environ. Microbiol.
66,
4772-4778[Abstract/Free Full Text]
|
| 48.
|
Bongaerts, R. J.,
Heinz, H. P.,
Hadding, U.,
and Zysk, G.
(2000)
Infect. Immun.
68,
7141-7143[Abstract/Free Full Text]
|
| 49.
|
Fischetti, V. A.,
Pancholi, V.,
and Schneewind, O.
(1990)
Mol. Microbiol.
4,
1603-1605[Medline]
[Order article via Infotrieve]
|
| 50.
|
Mazmanian, S. K.,
Liu, G.,
Ton-That, H.,
and Schneewind, O.
(1999)
Science
285,
760-762[Abstract/Free Full Text]
|
| 51.
|
Pancholi, V.,
and Fischetti, V. A.
(1988)
J. Bacteriol.
170,
2618-2624[Abstract/Free Full Text]
|
| 52.
|
Schneewind, O.,
Model, P.,
and Fischetti, V. A.
(1992)
Cell
70,
267-281[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Navarre, W. W.,
and Schneewind, O.
(1999)
Microbiol. Mol. Biol. Rev.
63,
174-229[Abstract/Free Full Text]
|
| 54.
|
Pallen, M. J.,
Lam, A. C.,
Antonio, M.,
and Dunbar, K.
(2001)
Trends Microbiol.
9,
97-102[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
Schneewind, O.,
Fowler, A.,
and Faull, K. F.
(1995)
Science
268,
103-106[Abstract/Free Full Text]
|
| 56.
|
Ton-That, H.,
Liu, G.,
Mazmanian, S. K.,
Faull, K. F.,
and Schneewind, O.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
12424-12429[Abstract/Free Full Text]
|
| 57.
|
Ton-That, H.,
Mazmanian, S. K.,
Alksne, L.,
and Schneewind, O.
(2001)
J. Biol. Chem.
277,
7447-7452[Abstract/Free Full Text]
|
| 58.
|
Mazmanian, S. K.,
Liu, G.,
Jensen, E. R.,
Lenoy, E.,
and Schneewind, O.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
5510-5515[Abstract/Free Full Text]
|
| 59.
|
Nelson, D.,
Loomis, L.,
and Fischetti, V. A.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
4107-4112[Abstract/Free Full Text]
|
| 60.
|
Fischetti, V. A.,
Gotschlich, E. C.,
and Bernheimer, A. W.
(1971)
J. Exp. Med.
133,
1105-1117[Abstract]
|
| 61.
|
Loeffler, J. M.,
Nelson, D.,
and Fischetti, V. A.
(2001)
Science
294,
2170-2172[Abstract/Free Full Text]
|
| 62.
|
Sim, R. B.
(1981)
Methods Enzymol.
80,
26-42
|
| 63.
|
Heimark, R. L.,
and Davie, E. W.
(1981)
Methods Enzymol.
80,
157-172
|
| 64.
|
Robbins, K. C.,
Summaria, L.,
and Wohl, R. C.
(1981)
Methods Enzymol.
80,
379-387
|
| 65.
|
Biswas, B.,
Adhya, S.,
Washart, P.,
Paul, B.,
Trostel, A. N.,
Powell, B.,
Carlton, R.,
and Merril, C. R.
(2002)
Infect. Immun.
70,
204-210[Abstract/Free Full Text]
|
| 66.
|
Drapeau, G. R.
(1976)
Methods Enzymol.
45,
469-475[Medline]
[Order article via Infotrieve]
|
| 67.
|
Lee, S. G.,
Roskoski, R., Jr.,
Bauer, K.,
and Lipmann, F.
(1973)
Biochemistry
12,
398-405[CrossRef][Medline]
[Order article via Infotrieve]
|
| 68.
|
Lee, S. G.,
and Lipmann, F.
(1974)
Proc. Natl. Acad. Sci. U. S. A.
71,
607-611[Abstract/Free Full Text]
|
| 69.
|
Lee, S. G.,
and Lipmann, F.
(1975)
Methods Enzymol.
43,
585-602[Medline]
[Order article via Infotrieve]
|
| 70.
|
Lee, S. G.,
and Lipmann, F.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
2343-2347[Abstract/Free Full Text]
|
| 71.
|
Mootz, H. D.,
and Marahiel, M. A.
(1997)
J. Bacteriol.
179,
6843-6850[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Raz and V. A. Fischetti
Sortase A localizes to distinct foci on the Streptococcus pyogenes membrane
PNAS,
November 25, 2008;
105(47):
18549 - 18554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Lodes, H. Secrist, D. R. Benson, S. Jen, K. D. Shanebeck, J. Guderian, J.-F. Maisonneuve, A. Bhatia, D. Persing, S. Patrick, et al.
Variable expression of immunoreactive surface proteins of Propionibacterium acnes
Microbiology,
December 1, 2006;
152(12):
3667 - 3681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Lee and V. A. Fischetti
Purification and Characterization of LPXTGase from Staphylococcus aureus: the Amino Acid Composition Mirrors That Found in the Peptidoglycan
J. Bacteriol.,
January 15, 2006;
188(2):
389 - 398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Selim, J. Negrel, C. Govaerts, S. Gianinazzi, and D. van Tuinen
Isolation and Partial Characterization of Antagonistic Peptides Produced by Paenibacillus sp. Strain B2 Isolated from the Sorghum Mycorrhizosphere
Appl. Envir. Microbiol.,
November 1, 2005;
71(11):
6501 - 6507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Lee and V. A. Fischetti
Presence of D-Alanine in an Endopeptidase from Streptococcus pyogenes
J. Biol. Chem.,
November 21, 2003;
278(47):
46649 - 46653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ariel, A. Zvi, K. S. Makarova, T. Chitlaru, E. Elhanany, B. Velan, S. Cohen, A. M. Friedlander, and A. Shafferman
Genome-Based Bioinformatic Selection of Chromosomal Bacillus anthracis Putative Vaccine Candidates Coupled with Proteomic Identification of Surface-Associated Antigens
Infect. Immun.,
August 1, 2003;
71(8):
4563 - 4579.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|